NovaMedica to localize in Russia one of the most popular anti-migraine drugs in the world
Merry Christmas and Happy New Year!
NovaMedica registers two own-development CNS products, one without equivalents in Russia and the other – in the world
A resource for anti-tumor drugs testing has been launched in Russia
Building a Community of Trust in Epilepsy & Rare Syndromes
MHRA approves prostate cancer combination therapy